Speech-Language Pathologists in Ashland, WI Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Rachel Mckian, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Main St W, Ashland, WI 54806 Phone: 715-685-2200

Ms. Jane Wiedmeyer Anderson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1319 Beaser Ave, Ashland, WI 54806 Phone: 715-682-3468

Mrs. Nancy Ellen Cholwek, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 618 Beaser Avenue, Ashland, WI 54806 Phone: 715-682-2363    Fax: 715-682-7244

Ms. Dianne J Litersky, M.A./CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 53686 Macdonald Rd, Ashland, WI 54806 Phone: 715-682-3388

Kristine Caroline Schmidt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 719 Main St E, Ashland, WI 54806 Phone: 715-685-2200    Fax: 715-685-2202

Mrs. Trisha A Rooni, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 61378 Hegstrom Rd, Ashland, WI 54806 Phone: 715-682-2092

Ms. Laura Anton Ia Nitsche, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 618 Beaser Avenue, Ashland, WI 54806 Phone: 715-682-2363    Fax: 715-682-7244

Mrs. Noelle Meyer, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1323 11th Ave W, Ashland, WI 54806 Phone: 715-562-0666

News Archive

IntegraGen, Lab21 collaborate to develop new microRNA assay for colorectal cancer

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.

Promising results from initial trial of new ultrasonic breast cancer screening

Scientists have successfully completed an initial trial of a new, potentially more reliable, technique for screening breast cancer using ultrasound. The team at the National Physical Laboratory (NPL), the UK's National Measurement Institute, working with the University Hospitals Bristol NHS Foundation Trust, are now looking to develop the technique into a clinical device.

BMC partners with RIH, CVS to support pharmacy-based naloxone rescue kits to help combat opioid addiction, overdose

Boston Medical Center has received a $1.3 million grant from the Agency for Healthcare Research and Quality to support a demonstration project of pharmacy-based naloxone rescue kits to help reduce opioid addiction and overdose death in two New England States: Massachusetts and Rhode Island.

Tecan introduces Spark 20M multimode microplate reader for drug discovery or life science research

Tecan has launched the Spark 20M multimode microplate reader, offering tailor-made solutions to suit virtually any drug discovery or advanced life science research application.

Study identifies tertiary treatment as an important source of antibiotic resistant genes

Water discharged into lakes and rivers from municipal sewage treatment plants may contain significant concentrations of the genes that make bacteria antibiotic-resistant. That's the conclusion of a new study on a sewage treatment plant on Lake Superior in the Duluth, Minn., harbor that appears in ACS' journal Environmental Science & Technology.

Read more Medical News

› Verified 4 days ago